Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype
Zohar Ravid
Chanock Centre for Virology, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorNatan Goldblum
Chanock Centre for Virology, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorRina Zaizov
Department of Pediatric Oncology, Beilinson Hospital, Petach Tikva, Israel
Search for more papers by this authorMichael Schlesinger
Hubert H. Humphrey Centre for Experimental Medicine and Cancer, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorTamar Kertes
Hubert H. Humphrey Centre for Experimental Medicine and Cancer, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorJun Minowada
Department of Immunology, Roswell Park Memorial Institute, Buffalo, N.Y., USA
Search for more papers by this authorWinston Verbi
Membrane Immunology Laboratory, Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England
Search for more papers by this authorMelvyn Greaves
Membrane Immunology Laboratory, Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England
Search for more papers by this authorZohar Ravid
Chanock Centre for Virology, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorNatan Goldblum
Chanock Centre for Virology, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorRina Zaizov
Department of Pediatric Oncology, Beilinson Hospital, Petach Tikva, Israel
Search for more papers by this authorMichael Schlesinger
Hubert H. Humphrey Centre for Experimental Medicine and Cancer, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorTamar Kertes
Hubert H. Humphrey Centre for Experimental Medicine and Cancer, Hebrew University-Hadassah Medical School, Jerusalem
Search for more papers by this authorJun Minowada
Department of Immunology, Roswell Park Memorial Institute, Buffalo, N.Y., USA
Search for more papers by this authorWinston Verbi
Membrane Immunology Laboratory, Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England
Search for more papers by this authorMelvyn Greaves
Membrane Immunology Laboratory, Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England
Search for more papers by this authorAbstract
We report the isolation and establishment in continuous culture of a human lymphoid cell line (Peer) from a case of T-leukemia. The Peer cell line lacks some typical cell-surface properties of T cells, namely sheep erythrocyte rosette formation and reactivity with two anti-T-cell sera, but has focal acid phosphatase and does express two other T-cell antigens, one defined by a monoclonal antibody, the other related to a T-cell subset (TH2). The cells are negative for B-cell markers (Smlg or cytoplasmic μ Fcγ and C3 receptors, mouse erythrocyte rosettes) and EBV (EBNA). In addition, the Peer cell does not possess the typical phenotypic markers of “non-B, non-T” leukemia: cALL and la-like antigens, and the cytoplasmic hexosaminidase isoenzyme I, but is positive for terminal deoxynucleotidyl transferase by enzymatic and immunofluorescent criteria. The cell line requires exogenous L-asparagine for adequate growth in culture, a property known to be characteristic of certain T cells but not of B cells. The Peer cell line appears to have a maturation arrest at a developmental stage intermediate between the cortical thymocyte and a mature T-cell subset and to have lost some T-cell differentiation features.
References
- Bach, J. F., Pleau, J. M., Dardenne, M. and Bach, M. A., Thymus dependency and biological significance of facteur thymique sërique (FTS). In: B. Serrou and C. Rosenfeld (eds.), Human lymphocyte differentiation: its application to cancer, pp. 179–286, Elsevier/North Holland Biomed. Press, Amsterdam (1978).
- BenBassat, H., Goldblum, N., Mitrani, S., Goldblum, T., Yoffey, J. M., Cohen, M. M., Bentwich, Z., Ramot, B., Kleine, and Klein, G., Establishment in continuous culture of a new type of lymphocyte from a “Burkitt-like” malignant lymphoma (Line D.G.-75). Int. J. Cancer, 19, 27–33 (1977).
- Bollum, F., Antibody to terminal deoxynucleotidyl transferase. Proc. nat. Acad. Sci. (Wash.), 72, 4119–4122 (1975).
- Borella, L., Sen, L., and Casper, J. T., Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette forming and non-E rosette forming ALL blasts. J. Immunol., 118, 309–315 (1977).
- Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., and Bodmer, W. F., Monoclonal antibodies for analysis of the HLA-system. Immunol. Rev., 47, 3–61 (1979).
- Brown, G., Capellaro, D., and Greaves, M. F., Leukaemia associated antigens in man. J. nat. Cancer Inst., 55, 1281–1289 (1975).
- Catovsky, D., Cherchi, M., Greaves, M. F., Janossy, G., Pain, C., and Kay, H. E. M., Acid phosphatase reaction in acute lymphoblastic leukaemia. Lancet, 1, 749–751 (1978).
- Catovsky, D., Cherchi, M., Okos, A., Hedge, U., and Galton, D. A. G., Mouse red cell rosettes in B lymphoproliferative disorders. Brit. J. Haematol., 33, 173–177 (1976).
- Chessells, J. M., Hardisty, R. M., Rapson, N. T., and Greaves, M. F., Acute lymphoblastic leukaemia in children: classification and prognosis. Lancett, 2, 1307–1309 (1977).
- Coleman, M. S., Greenwood, M. F., Hutton, J. J., Bollum, F. J., Lampkin, B., and Holland, P., Serial observations on terminal deoxynucleotidyl transferase activity and lymphoblast surface markers in acute lymphoblastic leukemia. Cancer Res., 36, 120–127 (1976).
- Ellis, R. B., Rapson, N. T., Patrick, A. D., and Greaves, M. F., Expression of hexosaminidase isoenzymes in childhood leukemia. N. Engl. J. Med., 298, 476–480 (1978).
- Evans, R. L., Lazarus, H., Penta, A. C., and Schlossman, S. F., Two functional distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J. Immunol., 120, 1423–1428 (1978).
- Greaves, M. F., Brown, G., Rapson, N. T., and Lister, T. A., Antiserum to acute lymphoblastic leukemic cells. Clin. Immunol. Immunopath., 4, 67–84 (1975).
- Greaves, M. F. and Janossy, G., Antisera to human T lymphocytes. In: B. Bloom and J. David (ed.), Methods in cell mediated immunity, 2nd Ed., pp. 89–104, Academic Press, New York (1976).
- Greaves, M. F., and Janossy, G., Patterns of gene expression and the cellular origins of human leukaemias. Biochem. Biophys. Acta, 516, 193–230 (1978).
- Grossowicz, N., Ariel, M., and Weber, T., Improved lysozyme assay in biological fluids. Clin. Chem., 25, 484–485 (1979).
- Hoffbrand, A. V., Ganeshaguru, K., Janossy, G., Greaves, M. F., Catovsky, D., and Woodruff, R. K., Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet, 2, 520–523 (1977).
- Janossy, G., Goldstone, A. H., Capellaro, D., Greaves, M. F., Kulenhampff, J., Pippard, M., and Welsh, K., Differentiation linked expression of p28, 33 (Ia-like) structures on human leukaemic cells. Brit. J. Haematol., 37, 391–402 (1977).
- Jondal, M., Holm, G., and Wigzell, H., Surface markers on human B and T lymphocytes. I. A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J. exp. Med., 136, 207–215 (1972).
- McMichael, A. J., Pilch, J. R., Galfre, G., Mason, D. Y., Fabre, J. W., and Milstein, C., A human thymocyte antigen defined by a hybrid monoclonal antibody. Europ. J. Immunol., 9, 205–210 (1979).
- Minowada, J., Janossy, G., Greaves, M. F., Tsubota, T., Srivastava, B. I. S., Morikawa, S., and Tatsumi, E., Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J. nat. Cancer Inst., 60, 1269–1277 (1978).
- Minowada, J., Ohnuma, T., and Moore, G. E., Rosetteforming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. nat. Cancer Inst., 49, 891–895 (1972).
- Moorhead, P. S., Nowell, P. C., Mellman, W. H., Battips, D. M., and Hungerford, D. A., Chromosome preparations of leukocytes cultured from human peripheral blood. Exp. Cell Res., 20, 613–616 (1960).
- Nakazawa, S., Minowada, J., and Finks, L. F., Receptors for sheep erythrocytes (E) and erythrocyte-antibody-complement complexes (EAC) on the lymphoblasts of childhood acute lymphoblastic leukemia. Med. pediat. Oncol., 2, 147–155 (1976).
- Ohnuma, T., Holland, J. F., Arkin, J., and Minowada, J., L-asparagine requirements of human T-lymphocytes and Blymphocytes in culture. J. nat. Cancer Inst., 59, 1061–1063 (1977).
- Reedman, M. M., and Klein, G., Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer, 11, 499–520 (1973).
- Reinherz, E. L. and Schlossman, S. F., Con A inducible supression of MLC: evidence for mediation by the TH2+ T-cell subset in man. J. Immunol., In press.
- Reissner, Y., Binyaminov, M., Rosenthal, E., Sharon, N., and Ramot, B. E., Interaction of peanut agglutinin with normal human lymphocytes and with leukaemic cells. Proc. nat. Acad. Sci. (Wash.), 76, 447–451 (1979).
- Roberts, M., Greaves, M. F., Janossy, G., Sutherland, R., and Pain, C., Acute lymphoblastic leukaemic (ALL) associated antigen. I. Expression in different haematopoietic malignancies. Leukemia Res., 2, 105–114 (1978).
- Welsh, K. I., and Turner, M. J., Preparation of antisera specific for human B cells by immunization of rabbits with immune complexes. Tissue Antigens, 8, 197–206 (1976).